Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

New P2X7 receptor antagonists emerge from Abbott R&D

March 24, 2006

Novel 5-HT7 receptor antagonists prepared and tested at Esteve

March 24, 2006

Encouraging preclinical results for oral NNZ-2566

March 24, 2006

VistaGen and Cato BioVentures sign strategic agreement for CNS products

March 24, 2006

Orphan drug designation for HD-02 for Huntington's disease

March 24, 2006

Second phase III study begins for Viprinex in acute ischemic stroke

March 24, 2006

FDA extends review period for Tysabri in MS

March 23, 2006

Samaritan's Alzheimer's adult stem cell drug progresses through preclinical testing

March 23, 2006

Asthma therapy efficacious in ALS

March 23, 2006

Aquavan begins pivotal phase III program

March 23, 2006

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...